[Epidemiological, clinical, therapeutic and evolutive aspects of Basedow-Graves disease in the Depatment of Internal Medicine at CHU Aristide Le Dantec, Dakar (Senegal)].
Basedow-Graves disease is an autoimmune affection characterized by the association of thyrotoxicosis with variable frequency events such as goiter, ophthalmopathy and pretibial myxedema. Its diagnosis is often easy, while its management remains difficult. A simple medical treatment exposes patient to recurrence risk. In Senegal and Sub-Saharan Africa few studies have focused on Basedow-Graves disease. This study aims to describe the epidemiological, clinical, therapeutic and evolutionary aspects of Basedow-Graves disease at a Hospital in Dakar. This was a retrospective study conducted from 1 January 2010 to 31 December 2013 in the Department of Internal Medicine at the Aristide Le Dantec University Hospital. During this period, 108 patients receiving outpatient treatment for Basedow-Graves disease were included out of a total of 834 patients receiving outpatient treatment. The diagnosis was made on the basis of clinical, biological and immunological signs. One hundred and eight patients suffering from Basedow-Graves disease were included out of a total of 834 consultations. Sex ratio was 7.3 and the average age was 34.6 years. The main reasons for consultation were: palpitations and weight loss in 46.3% and 39.8% of cases respectively. Thyrotoxicosis syndrome was found in 93.5% of patients, goiter was found in 87% of patients and exophthalmos in 78.7% of patients. The main complication was cardiothyreosis found in 11.1% of patients. All patients underwent antithyroid synthetic drugs treatment. The evolution was favorable in 19,4% of cases. Disease recurrence was observed in 57% of cases and in 23.1% of patients were lost to follow-up. Basedow-Graves disease is the most common cause of hyperthyroidism, The patient's clinical picture is dominated by manifestations related to hypermetabolism. This study highlights that thyroidectomy isn't the first-line of treatment if we consider the high number of recurrences after medical treatment.
Médecine Interne, Centre Hospitalier Universitaire Aristide Le Dantec, Dakar, Sénégal.
Nafissatou
N
Diagne
Médecine Interne, Centre Hospitalier Universitaire Aristide Le Dantec, Dakar, Sénégal.
Atoumane
A
Faye
Médecine Interne, Centre Hospitalier Universitaire Aristide Le Dantec, Dakar, Sénégal.
Awa Cheikh
AC
Ndao
Médecine Interne, Centre Hospitalier Universitaire Aristide Le Dantec, Dakar, Sénégal.
Boundia
B
Djiba
Médecine Interne, Centre Hospitalier Universitaire Aristide Le Dantec, Dakar, Sénégal.
Baidy Sy
BS
Kane
Médecine Interne, Centre Hospitalier Universitaire Aristide Le Dantec, Dakar, Sénégal.
Souhaibou
S
Ndongo
Médecine Interne, Centre Hospitalier Universitaire Aristide Le Dantec, Dakar, Sénégal.
Abdoulaye
A
Pouye
D000293:Adolescent; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000453:epidemiology / Q000209:etiology*; D005094:Exophthalmos / Q000453:epidemiology / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006042:Goiter / Q000453:epidemiology / Q000209:etiology; D006111:Graves Disease / Q000453:epidemiology* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D006980:Hyperthyroidism / Q000453:epidemiology / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D012675:Senegal / Q000453:epidemiology; D015431:Weight Loss; D055815:Young Adult
Autoimmunity; Dakar; hyperthyroidism